Director, Data Science - Measurement & Optimization at Gilead Sciences

Uxbridge, England, United Kingdom

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Deep expertise in developing marketing mix models and measurement frameworks, particularly within the pharmaceutical commercial domain
Ability to work closely with integrated insights, commercial ops, patient engagement, and omni-channel analytics leads
Skill in turning business insights into technical details and vice versa, acting as a conduit between business teams and data scientists
Knowledge of emerging digital and AI fields (e.g., Generative AI), focused on benchmarking and measurement
Ability to guide internal teams in making business decisions through value assessment, estimation, measurement planning, and execution
Hands-on functional expertise, highly collaborative mindset, and leadership skillsets
Experience leading data science projects end-to-end, including coding and debugging
Willingness to travel occasionally to global Gilead locations
Based in Stockley Park, UK, with 3 days a week in office

Responsibilities

Lead the development and delivery of models and methodologies to inform and evaluate brands' marketing and sales tactics (e.g., marketing mix, resource allocation) using latest data science techniques (ANCOVA, Bayesian Statistics, Econometrics, Neural Networks/Logistic, etc.)
Oversee and guide the development and execution of experiments (e.g., A/B and multi-variate tests) to assess the effectiveness of tactics, modifying initiatives as required
Lead the design of KPIs to track the effectiveness of recommendations that have been implemented and the measurement of campaigns' impact (e.g., ROI, engagement, lift, etc.)
Understand Gilead's commercial business objectives, develop and deploy scalable data science products and insights to influence decisions in marketing, sales, medical, etc
Lead data science projects end-to-end, including converting unstructured business questions into data science solutions, providing guidance to offshore teams, hands-on coding and debugging, and communicating with stakeholders
Foster a culture of measurement and impact and incorporate feedback to continuously improve data science models
Bring thought leadership in proactively applying innovative data science techniques and insights to drive/support strategic business decisions, including measurement solutions and resource optimization for commercial markets across Therapeutic Areas

Skills

Data Science

Marketing Mix Models

Measurement Frameworks

Resource Optimization

Commercial Analytics

Patient Engagement

Omni-Channel Marketing

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free